141 related articles for article (PubMed ID: 9265870)
1. Onychomycosis--a different perspective.
Epstein E
West J Med; 1997 Jul; 167(1):52-3. PubMed ID: 9265870
[No Abstract] [Full Text] [Related]
2. Oral treatment options for onychomycosis.
Joseph WS
J Am Podiatr Med Assoc; 1997 Nov; 87(11):520-31. PubMed ID: 9397657
[TBL] [Abstract][Full Text] [Related]
3. Cost effectiveness of continuous terbinafine compared with intermittent itraconazole in the treatment of dermatophyte toenail onychomycosis: an analysis of based on results from the L.I.ON. study. Lamisil versus Itraconazole in Onychomycosis.
Jansen R; Redekop WK; Rutten FF
Pharmacoeconomics; 2001; 19(4):401-10. PubMed ID: 11383756
[TBL] [Abstract][Full Text] [Related]
4. Economic evaluation of antifungal agents in the treatment of toenail onychomycosis in Germany.
Van Doorslaer EK; Tormans G; Gupta AK; Van Rossem K; Eggleston A; Dubois DJ; De Doncker P; Haneke E
Dermatology; 1996; 193(3):239-44. PubMed ID: 8944348
[TBL] [Abstract][Full Text] [Related]
5. Treatment of dermatophyte toenail onychomycosis in the United States. A pharmacoeconomic analysis.
Gupta AK
J Am Podiatr Med Assoc; 2002 May; 92(5):272-86. PubMed ID: 12015408
[TBL] [Abstract][Full Text] [Related]
6. Economic analysis of oral and topical therapies for onychomycosis of the toenails and fingernails.
Casciano J; Amaya K; Doyle J; Arikian S; Shear N; Haspel M; Kahler K
Manag Care; 2003 Mar; 12(3):47-54. PubMed ID: 12685377
[TBL] [Abstract][Full Text] [Related]
7. Pharmacoeconomic analysis of oral antifungal therapies used to treat dermatophyte onychomycosis of the toenails. A US analysis.
Gupta AK
Pharmacoeconomics; 1998 Feb; 13(2):243-56. PubMed ID: 10178650
[TBL] [Abstract][Full Text] [Related]
8. Onychomycosis: treatment perspective.
Jain S; Sehgal VN
Int J Dermatol; 2000 Jan; 39(1):10-4. PubMed ID: 10651956
[No Abstract] [Full Text] [Related]
9. [Pharmacoeconomic approach to onychomycosis therapy].
Glad'ko VV; Tarasenko GN
Voen Med Zh; 2002 Jun; 323(6):54-5. PubMed ID: 12140994
[No Abstract] [Full Text] [Related]
10. Curing onychomycosis: understanding the multitude of variables.
Lagana FJ
Clin Podiatr Med Surg; 2004 Oct; 21(4):555-64, vi. PubMed ID: 15450896
[TBL] [Abstract][Full Text] [Related]
11. Pharmacoeconomic analysis of the new oral antifungal agents used to treat toenail onychomycosis in the USA.
Gupta AK; Lambert J
Int J Dermatol; 1999 Sep; 38 Suppl 2():53-64. PubMed ID: 10515529
[No Abstract] [Full Text] [Related]
12. Continuous terbinafine or pulse itraconazole: a comparative study on onychomycosis.
Bahadir S; Inalöz HS; Alpay K; Agaoglu C; Cimsit G; Parlat P
J Eur Acad Dermatol Venereol; 2000 Sep; 14(5):422-3. PubMed ID: 11305391
[No Abstract] [Full Text] [Related]
13. Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents.
Piraccini BM; Sisti A; Tosti A
J Am Acad Dermatol; 2010 Mar; 62(3):411-4. PubMed ID: 20159308
[TBL] [Abstract][Full Text] [Related]
14. A cost/efficacy analysis of oral antifungals indicated for the treatment of onychomycosis: griseofulvin, itraconazole, and terbinafine.
Angello JT; Voytovich RM; Jan SA
Am J Manag Care; 1997 Mar; 3(3):443-50. PubMed ID: 10173095
[TBL] [Abstract][Full Text] [Related]
15. Treatment of toenail onychomycosis. Prescribing terbinafine to every patient with the condition would be expensive.
Rose P; Wilson T
BMJ; 1999 Oct; 319(7218):1197. PubMed ID: 10610152
[No Abstract] [Full Text] [Related]
16. Onychomycosis. New therapies for an old disease.
Gupta AK; Scher RK; De Doncker P; Sauder DN; Shear NH
West J Med; 1996 Dec; 165(6):349-51. PubMed ID: 9000854
[TBL] [Abstract][Full Text] [Related]
17. Oral treatment of onychomycosis.
Ellis MR; Kane KY
J Fam Pract; 1999 Apr; 48(4):252. PubMed ID: 10229245
[No Abstract] [Full Text] [Related]
18. Onychomycosis--treatment, relapse and re-infection.
Hull PR
Dermatology; 1997; 194 Suppl 1():7-9. PubMed ID: 9154393
[TBL] [Abstract][Full Text] [Related]
19. Onychomycosis: improved cure rates with itraconazole and terbinafine.
Harrell TK; Necomb WW; Replogle WH; King DS; Noble SL
J Am Board Fam Pract; 2000; 13(4):268-73. PubMed ID: 10933291
[TBL] [Abstract][Full Text] [Related]
20. The oral antifungal patient.
Joseph WS
Clin Podiatr Med Surg; 2004 Oct; 21(4):591-604, vii. PubMed ID: 15450899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
